Portfolio company
Corium
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops and commercialises central nervous system therapies and drug delivery systems for patients with neurological disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
SciNeuro Pharmaceuticals
This company develops neurological medicines and drug delivery platforms for patients with central nervous system diseases, including Alzheimer's and dementia.
Cerevel Therapeutics
This biopharmaceutical company develops neuroscience medicines for patients with mental and neurological conditions including schizophrenia, Parkinson's disease and epilepsy.
Newron
This biopharmaceutical company develops and commercialises therapies for patients with central and peripheral nervous system disorders, such as schizophrenia and Parkinson's disease.
nupathe-pharma
This company develops transdermal patches and biodegradable implants to deliver medication for central nervous system disorders like migraines and Parkinson's disease.
Arvelle Therapeutics
This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.
Civitas Therapeutics
This biopharmaceutical company develops inhaled drug delivery technologies for patients with neurological disorders such as Parkinson's disease.
SciNeuro Pharmaceuticals
The company develops therapeutic medicines and a delivery platform for patients with central nervous system and neurological diseases.
Cerevance
This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.
